Advent Pharma Ltd. (DSE:ADVENT)

Advent Pharma Revenue

In the fiscal year ending June 30, 2026, Advent Pharma had annual revenue of 401.85M BDT, down -19.71%. Advent Pharma had revenue of 93.78M in the quarter ending June 30, 2026, a decrease of -37.51%. That makes Advent Pharma the 41,321st largest company in the world by revenue and 250th in Bangladesh.

• Revenue: 401.85M
• Revenue Growth: -19.71%
• P/S Ratio: 3.29
• Revenue / Employee: 1.27M
• Employees: 317
• Market Cap: 1.34B

Revenue Chart

Chart

Chart

Revenue History

Fiscal Year End	Revenue	Change	Growth
Jun 30, 2026	401.85M	-98.64M	-19.71%
Jun 30, 2025	500.49M	-71.18M	-12.45%
Jun 30, 2024	571.67M	13.62M	2.44%
Jun 30, 2023	558.05M	27.58M	5.20%
Jun 30, 2022	530.47M	26.87M	5.34%

Data Source: S&P Global Market Intelligence Last updated: Oct 28, 2026

Revenue data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Nov 12, 2026

Data Sources Report a data error